Identification of novel biomarkers and drug targets for frailty-related skeletal muscle aging: a multi-omics study.

Qijun Wang, Xuan Zhao, Wei Wang, Xiaolong Chen, Shibao Lu

Department of Orthopedics & Elderly Spinal Surgery, Xuanwu Hospital of Capital Medical University, National Clinical Research Center for Geriatric Diseases, Beijing, China.Department of Orthopedics & Elderly Spinal Surgery, Xuanwu Hospital of Capital Medical University, National Clinical Research Center for Geriatric Diseases, Beijing, China. · pubmed

Paper

Abstract

Skeletal muscle aging is the major cause and hallmark of frailty, which poses a significant challenge to the healthcare system.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper identifies novel biomarkers and drug targets related to frailty and skeletal muscle aging. This research is relevant as it addresses underlying mechanisms of aging and frailty, which are critical for longevity and age-related health improvements.

Author of this paper? Send a correction.